Seattle Genetics | Ventes



Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Amgen USD 9.9B 340M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
Bayer EUR 9.66B 1.08B 2025-09
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 890K 160K 2025-09
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exelixis USD 598.66M 860K 2025-12
Genmab DKK 5.86B 580M 2025-06
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Incyte USD 1.51B 140M 2025-12
Insmed USD 142M 34.6M 2025-09
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
MacroGenics USD 72.84M 50.6M 2025-09
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 21M 22.61M 2025-09


Seattle Genetics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.